Probiotics Skin Randomized Trial Evidence Table

Structured evidence table for Probiotics Skin Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Probiotics Skin Randomized Trialobjective Theof this paper is to analyze the available scientific evidence on the cutaneous microbiome and its relationship with skin health.4Taléns‐Visconti Raquel (2026)Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions
Probiotics Skin Randomized Trialacnes 14 15 16 2 15 12 12 2 3 3 17 18 19 13 15 16 The skin microbiome shifts notably throughout life, from the low diversity observed in newborns, to the emergence of lipophilic species with puberty, and typically an increase in overall alpha diversity in older adults due to reduced dominance of protective commensals such asand, coupled with higher representation of environmental/transient species [,].4Taléns‐Visconti Raquel (2026)Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions
Probiotics Skin Randomized TrialA study found that women exhibit higher alpha diversity than men, indicating a richer and more balanced microbiota [].4Taléns‐Visconti Raquel (2026)Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions
Probiotics Skin Randomized Trial1 Human skin, owing to its large surface area, plays a key role as the primary point of direct contact with the environment.4Taléns‐Visconti Raquel (2026)Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions
Probiotics Skin Randomized TrialThis narrative review evaluates current evidence regarding the role of biotics in rosacea.4Avendaño-Pérez AL (2026)The Role of Biotics in Rosacea: A Narrative Review.
Probiotics Skin Randomized TrialEvidence supporting the use of prebiotics, postbiotics, and synbiotics in rosacea remains limited and, in many cases, extrapolated from related inflammatory conditions or preclinical models.4Avendaño-Pérez AL (2026)The Role of Biotics in Rosacea: A Narrative Review.
Probiotics Skin Randomized TrialAlthough microbiota modulation represents a promising therapeutic avenue, current evidence is insufficient to establish standardized clinical recommendations.4Avendaño-Pérez AL (2026)The Role of Biotics in Rosacea: A Narrative Review.
Probiotics Skin Randomized TrialRosacea is a chronic inflammatory dermatosis affecting the central face of adults, characterized by persistent erythema, flushing, papules, pustules, telangiectasias, and, in some cases, phymatous changes.4Avendaño-Pérez AL (2026)The Role of Biotics in Rosacea: A Narrative Review.
topicProbiotics Skin Randomized Trial
claimobjective Theof this paper is to analyze the available scientific evidence on the cutaneous microbiome and its relationship with skin health.
evidence level4
citationTaléns‐Visconti Raquel (2026)
sourceCosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions
topicProbiotics Skin Randomized Trial
claimacnes 14 15 16 2 15 12 12 2 3 3 17 18 19 13 15 16 The skin microbiome shifts notably throughout life, from the low diversity observed in newborns, to the emergence of lipophilic species with puberty, and typically an increase in overall alpha diversity in older adults due to reduced dominance of protective commensals such asand, coupled with higher representation of environmental/transient species [,].
evidence level4
citationTaléns‐Visconti Raquel (2026)
sourceCosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions
topicProbiotics Skin Randomized Trial
claimA study found that women exhibit higher alpha diversity than men, indicating a richer and more balanced microbiota [].
evidence level4
citationTaléns‐Visconti Raquel (2026)
sourceCosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions
topicProbiotics Skin Randomized Trial
claim1 Human skin, owing to its large surface area, plays a key role as the primary point of direct contact with the environment.
evidence level4
citationTaléns‐Visconti Raquel (2026)
sourceCosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions
topicProbiotics Skin Randomized Trial
claimThis narrative review evaluates current evidence regarding the role of biotics in rosacea.
evidence level4
citationAvendaño-Pérez AL (2026)
sourceThe Role of Biotics in Rosacea: A Narrative Review.
topicProbiotics Skin Randomized Trial
claimEvidence supporting the use of prebiotics, postbiotics, and synbiotics in rosacea remains limited and, in many cases, extrapolated from related inflammatory conditions or preclinical models.
evidence level4
citationAvendaño-Pérez AL (2026)
sourceThe Role of Biotics in Rosacea: A Narrative Review.
topicProbiotics Skin Randomized Trial
claimAlthough microbiota modulation represents a promising therapeutic avenue, current evidence is insufficient to establish standardized clinical recommendations.
evidence level4
citationAvendaño-Pérez AL (2026)
sourceThe Role of Biotics in Rosacea: A Narrative Review.
topicProbiotics Skin Randomized Trial
claimRosacea is a chronic inflammatory dermatosis affecting the central face of adults, characterized by persistent erythema, flushing, papules, pustules, telangiectasias, and, in some cases, phymatous changes.
evidence level4
citationAvendaño-Pérez AL (2026)
sourceThe Role of Biotics in Rosacea: A Narrative Review.

Source documents

  1. Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions
  2. The Role of Biotics in Rosacea: A Narrative Review.